These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1680830)

  • 1. Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity.
    Labroo VM; Hebel D; Kirk KL; Cohen LA; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1991 May; 37(5):430-9. PubMed ID: 1680830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion.
    Lazarus LH; Guglietta A; Wilson WE; Irons BJ; de Castiglione R
    J Biol Chem; 1989 Jan; 264(1):354-62. PubMed ID: 2562839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
    Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
    J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S; Sagan S; Delfour A; Nicolas P
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
    Ambo A; Niizuma H; Sasaki A; Kohara H; Sasaki Y
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1269-72. PubMed ID: 12657261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
    Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
    J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid peptides. Synthesis and binding assays of desamino-Tyr1 dermorphin analogues. XII.
    Salvadori S; Marastoni M; Balboni G; Tomatis R; Borea PA
    Farmaco Sci; 1987 Dec; 42(12):931-40. PubMed ID: 2896601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
    Salvadori S; Guerrini R; Borea PA; Tomatis R
    Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor binding profile of selected dermorphin-like peptides.
    Rossi AC; de Castiglione R; Perseo G
    Peptides; 1986; 7(5):755-9. PubMed ID: 2879276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and bioactivity of monobiotinylated DALDA: a mu-specific opioid peptide designed for targeted brain delivery.
    Bickel U; Yamada S; Pardridge WM
    J Pharmacol Exp Ther; 1994 Feb; 268(2):791-6. PubMed ID: 8113991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity.
    Schiller PW; Nguyen TM; Chung NN; Lemieux C
    J Med Chem; 1989 Mar; 32(3):698-703. PubMed ID: 2537427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contribution of C-terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency.
    Sagan S; Amiche M; Delfour A; Camus A; Mor A; Nicolas P
    Biochem Biophys Res Commun; 1989 Sep; 163(2):726-32. PubMed ID: 2551274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor.
    Attila M; Salvadori S; Balboni G; Bryant SD; Lazarus LH
    Int J Pept Protein Res; 1993 Dec; 42(6):550-9. PubMed ID: 7905867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of carboxyl-terminal extension analogs of dermorphin and evaluation of their opioid receptor-binding and opioid activities.
    Ambo A; Sasaki Y; Suzuki K
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):888-91. PubMed ID: 7912660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
    Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
    J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
    Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
    Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.